During dengue type 2 virus (DV) infection of mice a unique cytokine, the cytotoxic factor (CF), is produced which reproduces the pathological lesions seen in patients of dengue haemorrhagic fever (DHF). Recently we have observed a CF-like protein in the sera of DHF cases. The present study was undertaken to investigate whether DV can stimulate human peripheral blood mononuclear cells (PBMC) in vitro to produce human CF (hCF). Cultures prepared from PBMC or its enriched subpopulations were inoculated with 1000 LD50 of DV and controls with normal mouse brain suspension (NMB). Aliquots of cultures were harvested daily from 24 h to 96 h and their supernatant (CS) and cells were separated. CS were screened for viral titres and for the presence of hCF by cytotoxicity assay, inhibition ELISA, dot blot and Western blot tests using anti-mouse-CF antibodies. The RNA from the cells was screened in Northern blot and dot blot tests for the presence of mRNA for CF. It was observed that hCF appeared in the CS of DV-infected culture of PBMC and T-enriched cells at 48 h and was present until 96 h; no CF was detected in CS of B cells or monocyte cultures. The production of hCF was abrogated by pretreatment of the T cells with anti-CD4 antibodies but not with anti-CD8 antibodies, indicating that hCF was produced by CD4+ T cells. The Northern blot analysis using oligonucleotide probes prepared on the basis of amino-terminal sequence of mouse CF, showed presence of mRNA for hCF in PBMC and T cell cultures. DV replicated in PBMC cultures with peak titres at 48 h. The findings of the present study demonstrate that DV-induced hCF is produced by human T cells.
INTRODUCTION
Increased vascular permeability, thrombocytopenia, cerebral oedema and alterations in blood leucocytes are the cardinal features of dengue haemorrhagic fever/shock syndrome (DHF/ DSS). The pathogenesis of the disease is not fully known. A unique cytokine, the cytotoxic factor (CF) is produced by the T lymphocytes of dengue type 2 virus (DV)-infected mouse spleen [1] . It has recently been shown that CF is a pathogenesisassociated protein, capable of reproducing all the pathological lesions in mice that are seen in cases ofhuman dengue [2] [3] [4] . CF is a molecule of 22-25 kD on SDS-PAGE with an isoelectric point of pH . The N-terminal sequence of 19 amino acids of CF does not match with any other known cytokine or dengue virus-specific proteins [5] . Oligonucleotide probes derived from this sequence show the presence of mRNA for CF in the spleen cells of DV-infected mice by Northern blood leucocytes can be stimulated by DV in vitro to produce human CF (hCF). This is the first study to describe production of DV-induced CF by human CD4+ T cells.
MATERIALS AND METHODS

Mice
The study was carried out on inbred Swiss albino mice aged [2] [3] months, obtained from the colony maintained in this Department.
Virus
Dengue type 2 virus (DV), strain P23085, obtained from the National Institute of Virology (Pune, India), was used in the form of infected mouse brain suspension [6] . Similarly prepared Dengue virus-induced cytokine by the method of Reed & Muench [7] and expressed as logl0 LD50 per millilitre of the culture supernatant.
Preparation of PBMC Peripheral venous blood was collected from the authors (R.M. and U.C.C. alternately) in a heparinized tube. The leucocyterich plasma was removed and the PBMC consisting of monocytes and lymphocytes were separated as described earlier [8] . Briefly, the leucocyte-rich plasma was layered over Lymphoprep, density 1 077 g/ml (Nyegaard & Co. As., Oslo, Norway) and centrifuged at room temperature at 400 g for 30 min. The interface layer was collected, and the cells were washed three times with Hanks' basal salt solution (HBSS). The cells were counted and smears were stained with Giemsa stain to study cell morphology.
Preparation of enriched population of T and B cells Washed PBMC were passed through glass wool columns to remove monocytes and were then filtered through nylon wool columns to obtain an enriched subpopulation of T and B cells [9] . The cells were counted and 1 x 106 cells/ml were cultured for different assay.
Preparation of monocyte-enriched cells
The PBMC were suspended in Eagle's minimum essential medium (MEM) containing 5% fetal calf serum (FCS), layered in 4-cm Petri dishes (Nunclon, Nunc, Denmark) and incubated at 37°C in an atmosphere of 5% CO2 in air. After 2 h the Petri dishes were shaken and the non-adherent cells decanted. The process was repeated three times using fresh HBSS every time. Most of the glass-adherent cells were phagocytic, as shown by phagocytosis of latex particles [8] . These cells were therefore considered as monocytes in the present study.
Treatment of T cells with CD antibodies and complement
The enriched T cells were treated with mouse anti-human CD4 or CD8 MoAbs (Dako A/S, Glostrup, Denmark) and rabbit complement by the technique of Liew & Simpson [10] . The cells were washed three times and their viability estimated by trypan blue dye exclusion. The cells were counted and cultured. One set of cultures was inoculated with DV and the controls with NMB. The cultures were harvested at 24, 48, 72 and 96 h and the culture supernatants (CS) and cells were collected for screening for the presence of hCF.
Preparation of cell cultures
The PBMC or its enriched subpopulation of cells (1 x 106 cell/ ml) were cultured in MEM containing 5% FCS using 4-cm Petri dishes (Nunclon; Nunc). The cultures were inoculated with 1000 LD50 of DV, and the control cultures with NMB; tubes were incubated at 37°C in the presence of 5% CO2 for various time periods. All the cultures were set in triplicate and the experiments repeated at least three times. CS were tested for the presence of hCF by cytotoxicity, ELISA and dot blot assay. The cells were processed to isolate total RNA for Northern blot test to screen the presence of hCF-specific mRNA.
Assay of cytotoxic activity The cytotoxic activity of preparations was assayed using normal mouse End-labelling of oligonucleotides The two oligomers used were: 5' TGG CTC TAG ACA 3' and 5' TGG TTC TAG ACA 3'. The sequence of the above oligomers was chosen from the N'-terminal sequence of mouse CF [5] and was prepared by CSIR Biochemical Biotechnology (New Delhi, India). To 1 pl of the oligomer was added 10 x kinase buffer containing cocktail of dNTPs, T4-polynucleotide kinase, water and 30 ACi 32P--yATP, final volume 10 p1 [13] . The mixture was incubated at 370C for 30 min and then loaded on a Sephadex G25 column. The labelled oligonucleotides were recovered from the column with water and tested for specific radioactivity.
RNA isolation and Northern blot analysis
At different time periods after exposure of leucocytes, T lymphocytes and B lymphocytes from human blood to DV, total RNA was isolated by acid guanidinium-thiocyanatephenol-chloroform extraction method, as described by Chomczynski & Sacchi [12] . The RNA was quantified spectrophotometrically and its integrity examined by electrophoresis.
For Northern blot analysis, 20 pg of total RNA per lane from each group was applied and separated by electrophoresis on 1% agarose gel under denaturing conditions [13] . The RNA was then transferred to NC membrane using the LKB Vaccugene blotting system. RNA was immobilized on NC membrane by vacuum baking at 80'C for 2 h. The blots were prehybridized for 4 h at room temperature in presence of saline sodium citrate buffer (SSC, 5 x ), 5 x Denhardt's solution, 1 mM EDTA, and were subsequently hybridized in the same mixture containing 32P-labelled oligonucleotides for 15 h at 42°C under gentle shaking [13, 14] . After hybridization, the NC membrane was washed three times for 10 min at 42°C in 2 x SSC and 0 2% SDS, and three times for 20 min in 0 1 x SSC and 0 1% SDS. The NC membrane was exposed at -70°C to Kodak x-ray film with intensifying screen. Autoradiograms were developed 7-10 days after exposure. For dot blot analysis 5 pg of total RNA were blotted directly onto NC membrane in a Milliblot System (Millipore Corporation) and hybridized as described above.
Statistical analysis Data were analysed using Student's t-test. P < 0 05 was considered significant.
RESULTS
Detection of hCF by cytotoxic activity A peak cytotoxicity of 39 + 7% was observed in the CS collected at 48 h following DV inoculation in PBMC cultures. At later periods, activity was slightly reduced (P > 0 05). A peak activity of 7 + 2% was observed in culture inoculated with NMB (Fig. la) . Activity in CS from enriched DV-inoculated T cell was little less, maximum being 29 5% (Fig. Ib) , while CS from B cells or monocyte-enriched cultures had no cytotoxic activity (Fig. lc,d ). Detection of hCF by ELISA An inhibition ELISA done to detect the presence of CF in CS of DV-inoculated cultures showed a peak inhibition of 48 + 5% at 48 h in PBMC (Fig. 2a) . A similar pattern was seen with CS from T cell-enriched cultures (Fig. 2b) , while CS from B cells or monocyte-enriched cultures had insignificant (P > 0 5) inhibitory activity (Fig. 2c,d ). Fig. 1 Fig. 3 . The data presented in Fig. 4 (Fig. 4) .
hCF production by antibody-treated cells
The findings presented in Fig. 5 show that production of hCF was abolished by pretreatment of the T-enriched cells with anti- After washing, one set of the cells was inoculated with dengue virus (DV) (0), the second set with normal mouse brain homogenate (NMB) (E) and the third set was an uninoculated control for blank. The cultures were incubated at 37°C in presence of 5% CO2 for 48 h and the CS were collected. Cytotoxic activity of the CS was assayed as in Fig. 1 . The mean value ± s.d. from 15 observations of each sample is presented.
CD4 antibodies as shown by cytotoxicity assay (6 ± 2%). Treatment with anti-CD8 antibodies had no effect on the production of hCF (cytotoxicity 31 ± 7%). Similar findings were observed when the CS from this experiment was assayed by ELISA for the presence of hCF (data not shown).
Detection of mRNA for hCF Autoradiograms of the Northern blot and dot blot analysis of mRNA for hCF are presented in Fig. 6a,b . A positive reaction with CF-specific oligonucleotide probe was observed with DV-stimulated PBMC and T cells, but not with B cells. A faint reaction was observed with control T cells and PBMC (Fig. 6a) . An effort was made to identify the cell type in human peripheral blood leucocytes, responsible for the production of CF on stimulation by DV. It was observed that T cells were responsible for the production of hCF. The findings of the following experiments supported this conclusion on the basis of ELISA and cytotoxicity assay: (i) CF activity was similar in the CS from T cell-enriched (monocyte-and B cell-depleted) and PBMC subpopulation (P > 0 05); (ii) CS from B cell-enriched population had no activity; (iii) CS from monocyte-enriched population had no hCF activity. These findings were confirmed by dot blot test also. Treatment of T cells with anti-CD4 antibody and complement abrogated the production of hCF, while treatment with anti-CD8 antibody and complement had no effect. This strongly suggested that hCF was produced by CD4 + T cells. This is similar to the mouse CF which is produced by L3T4 + splenic T cells ( [1, 15] , unpublished data). Further, the expression of mRNA in PBMC and T cells reflected synthesis of hCF by the cells following stimulation by DV. Detection of a cytokine by expression of mRNA is a much more sensitive and specific technique, and has been used in PBMC by in situ hybridization [16] .
The virus antigen is detectable in the spleen of mice, inoculated intracerebrally with DV by immunofluorescence from day 4 and the titre of the virus reaches peak levels from day 8 [17] . The CF is detectable in the spleens of such mice from day 6, reaching peak cytotoxic activity on days 10-11 [1] . In the present study DV was detectable throughout the period of study, with peak virus titres at 48 h, and the hCF was detected at 48 h after DV inoculation in the cultures and persisted to similar levels up to hour 96 of the study. On the other hand, PBMC cultures inoculated with heat-killed DV showed neither the virus nor the production of hCF (data not shown). A similar time schedule is observed when mouse spleen cell cultures are infected with DV (unpublished data). DV has been shown to replicate in vitro in B-type lymphoblastoid cells; in mitogen-stimulated peripheral blood lymphocytes; in macrophages; and possibly in specifically sensitized lymphocytes (reviewed in [18] ). It has been observed that the presence of macrophages is obligatory for the presentation of DV antigen to B cells, leading to their clonal expansion and consequent immune response. The B cells as such are incapable of receiving the native DV antigen [19, 20] . The findings of the present study show that induction of hCF production by DV does not require any accessory cells; DV could directly stimulate T cells to produce hCF (Fig. lb, 2b) .
Mouse CF is a pathogenesis-associated protein and is capable of reproducing all the pathological lesions in mice that are seen in cases of DHF, e.g. increase in vascular permeability, cerebral oedema, and alterations in leucocyte number and functions [2, 3, 18] . Mouse and hCF have shown a number of similarities, namely (i) hCF could be detected in ELISA, dot blot and Western blot by anti-mouse CF antisera; (ii) the electrophoretic migration of both the CF is the same, as shown in the Western blot test (Fig. 4) ; (iii) mRNA for hCF could be detected by oligonucleotide probes derived from the amino acid sequence of mouse CF; and (iv) cytotoxic activity on normal mouse spleen cells is similar by both of them. Efforts are being made to purify and determine the amino acid sequence of hCF so that its homology (if any) with mouse CF is determined. This will also explain the presence of crossreacting antigens on the mouse CF and hCF. The cDNA library for mouse CF has been constructed and the recombinant CF has been expressed in Escherichia coli (U.C. Chaturvedi et al., manuscript in preparation). There is a need to produce larger quantities of hCF so that it may be characterized fully.
